Problems associated with bioavailability and dosage regimen studies in man-Reference-Cited by-同舟云学术

Problems associated with bioavailability and dosage regimen studies in man

Published:1974-08 Issue:4 Volume:2 Page:365-377
ISSN:0090-466X
Container-title:Journal of Pharmacokinetics and Biopharmaceutics
language:en
Short-container-title:Journal of Pharmacokinetics and Biopharmaceutics

Author:

Wolen Robert L.,Rubin Alan,Rodda Bruce E.,Ridolfo Anthony S.,Gruber Charles M.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics

Link

http://link.springer.com/content/pdf/10.1007/BF01061408.pdf

Reference14 articles.

1. Federal Register, March 17, 1971, 36FR5037.

2. H. C. Shirkey. Therapeutic orphans.J. Infect. Dis. 121: 348–350 (1970).

3. J. G. Wagner.Biopharmaceutics and Relevant Pharmacokinetics, Drug Intelligence Publications, Hamilton, Ill., 1971.

4. W. Westlake. In J. Swarbrick (ed.),Current Concepts in Pharmaceutical Sciences: Dosage Form Design and Bioavailability, Lea and Febiger, Philadelphia, 1973, pp. 149–180.

5. C. M. Gruber. Jr., and T. Collins. Antipyretic effects of fenoprofen.J. Med. 3: 242–248 (1972).

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The pharmacokinetics and bioavailability of subcutaneously administered dihydroergotamine, heparin and the dihydroergotamine-heparin combination;Thrombosis Research;1983-07

2. A Bibliography for Selected Pharmacokinetic Topics;Drug Intelligence & Clinical Pharmacy;1980-11

3. Bioavailability and genetic prescribing;Survey of Ophthalmology;1976-11

4. BIOAVAILABILITY TESTING IN MAN: PHARMACOKINETIC CONSIDERATIONS;The Quality Control of Medicines;1976